OQS
CAPR icon

Occudo Quantitative Strategies’s Capricor Therapeutics CAPR Stock Holding History

Occudo Quantitative Strategies’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25,151
Closed -$120K – 732
2024
Q2 		$120K Sell
25,151
-906
-3% -$5.05K 0.02% 652
2024
Q1 		$177K Buy
+26,057
New +$126K 0.03% 611
2021
Q1 		– Sell
-15,188
Closed -$52K – 766
2020
Q4 		$52K Buy
+15,188
New +$65.9K 0.02% 614

Other funds holding CAPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Occudo Quantitative Strategies's CAPR Position: Q3 2024 in Review

Occudo Quantitative Strategies sold out of Capricor Therapeutics (CAPR) in Q3 2024, closing a stake of 25,151 shares — an estimated $120K sold.

Occudo Quantitative Strategies first reported a position in CAPR in Q4 2020 and held it in 3 quarters. The position peaked at $177K in Q1 2024. 75 funds tracked by Wall St. Rank hold CAPR as of Q3 2024.

  • Occudo Quantitative Strategies reported no remaining Capricor Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 25,151 Capricor Therapeutics shares in Q3 2024, an estimated $120K.
  • Occudo Quantitative Strategies first reported a position in Capricor Therapeutics in Q4 2020 and held it in 3 quarters.
  • Occudo Quantitative Strategies's Capricor Therapeutics position peaked at $177K in Q1 2024.
  • 75 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.